$20 million for research into childhood brain cancers

The Australian Government has announced $20 million for research into new treatments for Diffuse Intrinsic Pontine Glioma (DIPG) and other childhood brain cancers. Funding is from the Medical Research Future Fund (MRFF).

Date published:
Type:
News
Audience:
General public

While the overall survival rate for childhood cancer is now over 80%, brain cancers are the most common solid tumours in children. Brain cancers also cause more deaths in children than any other cancer.

The MRFF’s 2024 Paediatric Brain Cancer Research grant opportunity will provide $20 million over 7 years for clinical trials and work to find new treatments. As part of this research program, a new National Childhood Brain Cancer Clinical Trial Consortium will:

  • promote collaboration between countries and across the research sector to develop new research approaches
  • work to improve priority populations’ access to clinical trials.

Funding is from the MRFF’s Emerging Priorities and Consumer-Driven Research initiative.

Read the media release.

Visit GrantConnect for more information.

Learn more about the MRFF.

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.